Piper Jaffray Raises PT On Luminex To $19

Piper Jaffray has raised the price target on Luminex LMNX from $17 to $19 and maintains its Underweight rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetAnalyst RatingsHealth CareLife Sciences Tools & ServicesPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!